comparemela.com

Latest Breaking News On - Bessemer group inc - Page 8 : comparemela.com

Capri's (CPRI) Market Perform Rating Reiterated at Telsey Advisory Group

Telsey Advisory Group restated their market perform rating on shares of Capri (NYSE:CPRI – Free Report) in a research note issued to investors on Thursday, Benzinga reports. Telsey Advisory Group currently has a $42.00 price target on the stock. Other analysts have also recently issued reports about the company. StockNews.com initiated coverage on Capri in […]

United-states
Switzerland
Canada
America
Swiss
Jimmy-choo
Michael-kors
Third-bancorp
Capri-company-profile
Bessemer-group-inc
Swiss-national-bank
Wealth-management-group

SAP (NYSE:SAP) Research Coverage Started at Sanford C. Bernstein

Sanford C. Bernstein assumed coverage on shares of SAP (NYSE:SAP – Free Report) in a report released on Thursday, Marketbeat reports. The firm issued an outperform rating and a $227.00 price objective on the software maker’s stock. A number of other research firms have also weighed in on SAP. JMP Securities raised their price objective […]

Sanfordc-bernstein
Sage-rhino-capital
Haverford-trust-co
Contravisory-investment-management-inc
Argonautica-private-wealth-management-inc
Keycorp
Goldman-sachs-group
Bessemer-group-inc
Company-profile
Jefferies-financial-group
Free-report

Insider Selling: Criteo S.A. (NASDAQ:CRTO) Major Shareholder Sells $57,087.80 in Stock

Criteo S.A. (NASDAQ:CRTO – Get Free Report) major shareholder Till Hufnagel sold 1,540 shares of Criteo stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $37.07, for a total value of $57,087.80. Following the completion of the sale, the insider now directly owns 1,759,275 shares […]

United-states
America
Keycorp
Criteo-company-profile
Sei-investments-co
Bessemer-group-inc
Jpmorgan-chase-co
Covestor-ltd
Wells-fargo-company
Get-free-report
Till-hufnagel

HC Wainwright Trims Cytokinetics (NASDAQ:CYTK) Target Price to $90.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price target lowered by HC Wainwright from $94.00 to $90.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. CYTK has been the topic of several other research reports. JMP Securities reduced their price target on shares […]

Johnt-henderson
Raymond-james
Fady-ibraham-malik
Barclays
Third-bancorp
Fifth-third-bancorp
Bessemer-group-inc
Nasdaq
Securities-exchange-commission
Entrypoint-capital
Sage-rhino-capital

Bank of America Cuts Cytokinetics (NASDAQ:CYTK) Price Target to $60.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price target lowered by Bank of America from $70.00 to $60.00 in a research report report published on Thursday, Benzinga reports. The firm currently has a neutral rating on the biopharmaceutical company’s stock. Other equities research analysts have also issued reports about the company. Barclays decreased their target […]

United-states
America
Raymond-james
Johnt-henderson
Fady-ibraham-malik
Sage-rhino-capital
Cytokinetics-incorporated
Securities-exchange-commission
Entrypoint-capital
Barclays
Cytokinetics-company-profile
Bessemer-group-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.